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Abstract Here we provide a protocol for the directed differ-
entiation of hEPI-NCSC into midbrain dopaminergic neurons,
which degenerate in Parkinson’s disease. hEPI-NCSC are
neural crest-derived multipotent stem cells that persist into
adulthood in the bulge of hair follicles. The experimental
design is distinctly different from conventional protocols
for embryonic stem cells and induced pluripotent stem
(iPS) cells. It includes pre-differentiation of the multipotent
hEPI-NCSC into neural stem cell-like cells, followed by
ventralizing, patterning, continued exposure to the TGFβ
receptor inhibitor, SB431542, and at later stages of differ-
entiation the presence of the WNT inhibitor, IWP-4. All
cells expressed A9 midbrain dopaminergic neuron progen-
itor markers with gene expression levels comparable to
those in normal human substantia nigra. The current study
shows for the first time that virtually homogeneous popula-
tions of dopaminergic neurons can be derived ex vivo from
somatic stem cells without the need for purification, with
useful timeliness and high efficacy. This novel development
is an important first step towards the establishment of fully
functional dopaminergic neurons from an ontologically rele-
vant stem cell type, hEPI-NCSC.
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Introduction
Generating large numbers of neurons for disease modeling,
drug discovery and future cell replacement therapy in
Parkinson’s disease is an active and promising field of
research in which much progress has been achieved in
recent years. Chambers et al. [1] showed that dual SMAD
inhibition leads to complete neural conversion of human
embryonic stem cells (hESC). The same group built on
this observation and generated a cell population of which
60–80 % expressed the neuronal marker genes NURR1,
LMX1a, FOXA2 and tyrosine hydroxylase (TH) by day
50 in culture [2]. The authors did not, however, show that
the cells also expressed the key midbrain marker EN1.
Subsequently, Xi et al. [3] reported a study in which
populations with up to 87 % cells double positive for
NURR1 and FOXA2 were obtained from human embry-
onic stem cell (hESC) cell lines by day 28 of culture.
Approximately 20 % of total cells were triple positive for
the marker genes TH, GIRK2 and EN1, and were thus
identified as A9 dopaminergic neurons. Overall, current
state-of-the art methods yield populations that after
prolonged periods of time in culture are enriched to vary-
ing degrees with cells that show characteristics of func-
tional dopaminergic neurons. Clearly, however, in order to
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furnish the above experimental and clinical aims, there
remains a need to improve upon the efficiency and effec-
tiveness of the differentiation process.
hEPI-NCSC are multipotent somatic stem cells, which are
remnants of the embryonic neural crest and persist postnatally
and into adulthood in the bulge of hair follicles [4–8]. By
taking advantage of the migratory ability of neural crest
cells, hEPI-NCSC can be isolated as a highly pure popula-
tion of multipotent stem cells [5]. hEPI-NCSC can be
expanded ex vivo rapidly into millions of stem cells and
they can differentiate into all major neural crest derivatives
[9]. In mouse models of spinal cord injury, intraspinal
mouse EPI-NCSC elicited significant improvement in sen-
sory connectivity through generating GABAergic neurons,
re-myelination, neurotrophic support and modulation of
scar formation [10, 11]. Embryonic neural crest cells emi-
grate from the dorsal aspect of the neural tube along the
entire neuraxis and invade the embryo by various routes
[12]. A subset of multipotent neural crest cells migrates
below the ectoderm and subsequently invades the ectoderm
[13] to develop into melanocytes, which give skin and hair
their color, and to form a reservoir of multipotent neural
crest-derived stem cells in the follicular bulge. By contrast,
midbrain dopaminergic neurons are born in the ventral
neural tube at the isthmus, the zone of convergence of
three growth factors essential for dopaminergic neuron
development, fibroblast growth factor 8 (FGF8), sonic
hedgehog (SHH) and WNT proteins [14].
The rationale behind the current study was three-fold. First,
active canonical WNT signaling, which is a prerequisite for
midbrain dopaminergic neuron differentiation, is a hallmark
of neural crest cells. Second, similar to midbrain floor plate
cells, the neural crest is predestined to generate catechol-
aminergic neurons, as it gives rise to the autonomic and
enteric nervous systems. Third, neural crest stem cells are
ontologically closely related to central nervous system pre-
cursor cells, as during embryonic development a higher
order stem cell generates both spinal cord progenitor cells
and neural crest stem cells [15]. We therefore based the
experimental design on commonalities and differences in
embryonic development of neural crest cells and midbrain
dopaminergic neuroblasts.
Fig. 1 Phase contrast images of differentiating hEPI-NCSC. ahEPI-NCSC
with stellate morphology in expansion culture prior to differentiation. bBy
differentiation day 4, virtually all cells were bipolar with short processes.
Bar, 100 μm. c In the presence of IWP-4 virtually all cells were multipolar
with long processes and dopaminergic neuron morphology. In contrast, in
the absence of IWP-4, the majority of cells often, but not always, flattened
and lost neuronal morphology by day 14–18 (C’). Many neurons appeared
unhealthy (e.g., arrow) and subsequently died. In subsequent days there
were areas with widespread cell death (C”). Bar, 100 μm. dBy day 25–30
differentiated cells had assumed mature multipolar neuronal morphology
with phase-bright somata. Bar, 50 μm
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Materials
Equipment
Class II safety hood
Two-gas incubator at 5%CO2 and 5%O2
Inverted microscope
Dissecting microscope
Fluorescence microscope
Thermocycler
Andor Revolution XD System or other means to capture
calcium flux
Illumina platform
Reagents
NP2medium consisted of D-MEM/F-12/GlutaMAX, 1x Pen/
Strep, FBS (1 %); ITS+3 or SITE+3, β-mercaptoethanol
(10 μM), Heparin (2 μg/ml); EGF (20 ng/ml); rhFGF2
(10 ng/ml) and NT-3 (10 ng/ml).
Patterning and differentiation was achieved in DMEM-
F12-Glutamax medium that was supplemented with 1 % fetal
bovine serum (FBS; where indicated), penicillin/streptomycin,
SHH-C24II (500 ng/ml; 100 ng/ml), FGF8b (10 ng/ml),
rhGDNF (5 ng/ml), rhBDNF (20 ng/ml), db c-AMP (1 mM)
ascorbic acid (200 μM), and CHIR99021 (0.5 μM; where
indicated), B27 (minus vitamin A) supplement, brain derived
neurotrophic factor (rhBDNF, 20 ng/ml), glial cell line derived
factor (GDNF, 5 ng/ml), ascorbic acid and dibutyryl cyclic
AMP (db c-AMP; 100–500 μM). The WNT inhibitor, IWP-4
[ref 37] (100 nM days 4–6; 1 μM thereafter), SB431542
(10 μM) and LDN-193189 (100 nM) were added as indicated.
Sources of materials are listed in Supplemental Table 1. Cells
were seeded at 2,500–5,000 cells per CellStart-coated 35-mm
plate. They were sub-cultured once onto poly-D-lysine
(20 μg/ml), fibronectin (2 μg/ml) and laminin (1 μg/ml) coated
glass coverslips at various times during differentiation and at
different cell densities. Neither the timing of subculture nor the
seeding density grossly affected differentiation, except that at
late stages of in vitro differentiation not all cells resumed the
phase bright multipolar neuronal morphology, but tended to
remain flattened. Culture medium needs to be exchanged
with fresh medium every other day. Sources for reagents are
provided in Supplemental Table 1.
Fig. 2 Experimental design. Cells from primary explants were expanded
ex vivo for 7 days exactly as we have described previously [9], cryopre-
served and subsequently used for differentiation experiments. Cells were
seeded at 2,500–5,000 cells per 35mm plate and cultured in NP2medium
for up to 6 days in a humidified atmosphere at 5 % CO2 and 5 % O2. We
determined, however, that 24 h in NP2 medium is the minimal require-
ment. After 24 h in NP2 medium, FGF8, rhSHH C24II (500 ng/ml),
LDN-193189, SB431542, B27 without retinoic acid, NGF, BDNF,
GDNF, ascorbic acid and db-cAMP were added, as well as CHIR99021
(0.5 μM). The latter was removed after 24 h. At day 4, IWP-4 (100 nM),
was added. At day 6, the IWP-4 dose was increased to 1 μM. At various
times thereafter cells were sub-cultured using TrypLE and re-seeded onto
poly-lysine and laminin-coated 13 mm glass coverslips at 6,000 cells per
cm2 and culturing continued for various periods of time
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Methods
Primary explants were obtained exactly as we have
described previously [9]. De-identified pubic hairy skin biopsies
were obtained with ethical approval (REC REF: 08/H0907/1)
from consenting individuals undergoing repeat elective Cae-
sarean sections. The cells were obtained and expanded
ex vivo exactly as we have described previously [9].
Indirect immunocytochemistrywas performed exactly as
we have described previously [9]. In brief, cells on glass
coverslips were fixed with 4 % paraformaldehyde (PFA),
rinsed, blocked (2% goat serum or 1 % bovine serum albumin
[BSA]), primary antibodies added and incubated overnight
in the cold. Cultures were then rinsed, incubated with
fluorescent-conjugated secondary antibodies (1:200), rinsed
and finally mounted with a slide and Vectashield-plus-DAPI
(Vector Laboratories, Cat# H-1500). Sources and dilutions of
antibodies are listed in Supplemental Table 1.
Real-time polymerase chain reaction (qPCR) was per-
formed exactly as we have described previously [9]. Briefly,
cDNA was synthesized following RT-PCR and set up for
PCR reaction as follows: 15 μl SYBR Green (Sigma Cat#
S4438), 12 μl ddH20, 1.5 μl cDNA, 1.5 μl primer set
(SABiosciences), 10 μl aliquots delivered into three wells
of a 384 well plate (Greiner Cat# 785290), and amplified in
a Taqman 7900HT thermocycler as follows: 95 °C, 10 min
followed by 40 cycles of 95 °C (15 s), 60 °C (60 s) and
70 °C (30 s), followed by melting curve analysis to confirm
single product amplification. For analysis the average of the
Ct triplicates for the PCR product of each gene was deter-
mined, normalized against the average of three housekeep-
ing genes (HKG), glyceraldehyde 3-phosphate dehydroge-
nase (GAPDH), TATA box binding protein (TBP), succinate
dehydrogenase complex subunit A (SDHA) and expressed
as a percentage of the average of the three HKG. Primer
pairs are listed in Supplemental Table 1.
Fig. 3 Immunocytochemistry at day 5 of culture. At day 5, all cells
expressed OTX2 (a) in the nucleus. FOXA2 (A’, A”) merged images with
DAPI nuclear stain. FOXA2 was expressed in 89.2±17.4 % of nuclei,
but was expressed also in perinuclear areas (see also Tables 1 and 2).
b 93.1±11.1 % of cells expressed NURR1. (B’) All cells expressed
TH in the cytoplasm in perinuclear areas (inset; higher magnification),
but not in distal processes. (B”) Merged images with DAPI nuclear
stain. c All cells expressed EN1 in perinuclear areas and at lower
intensity also in the nucleus. (d, D’) All cells expressed β-III tubulin.
Bar, (a–d; D’), 50 μm
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Human Substantia Nigra Frozen midbrain cryo-sections
(15 μm) of human substantia nigra from three healthy donors
were obtained from Parkinson’s UK Brain Bank, Centre for
Neuroscience, Imperial College, London. The readily identi-
fiable dark substantia nigra was microdissected under
brightfield optics, the tissue collected, pooled, dissolved in
TRIzol and subsequently processed for real-time PCR.
Calcium Imaging Changes in [Ca2+]i were assessed using the
calcium-sensitive dye Fluo-4. Cells grown in μ-Slides (IBIDI
cat#80821) were loaded with 1 μM Fluo-4 AM and 0.02 %
Pluronic F-127 in culture medium for 35 mins at 37 °C and
maintained on the stage of a temperature-controlled (36.8 °C)
inverted Olympus IX81 microscope. The Fluo-4-loaded cells
were washed twice with HEPES buffer (NaCl 145 mM;
MgSO4 1 mM; KCl 5 mM; glucose 10 mM; CaCl2 2.5 mM;
HEPES 10 mM; pH 7) and then allowed to equilibrate for
20 min. Fluo-4 fluorescence images (488 nm excitation,
525 nm emission, 50 nm long-pass filter) were collected and
recorded using an Andor Revolution XD System with Andor
IQ software version 1 (Belfast, UK). Images were acquired at
12–25 frames per sec for up to 2 mins. Real-time movie files
of continuously recorded data were viewed to assess changes
in cellular fluorescence occurring spontaneously or in response
to agonist stimulation. The number of cells exhibiting calcium
fluctuations were noted as percentage of all cells in the field of
view. After equilibration, activity was recorded in HEPES
buffer (spontaneous activity) and following the addition to
the dish of either 300 μM ATP, 30 μM acetylcholine, 10 μM
phenylephrine, 50 μM L-glutamate or 80 mM KCl (HEPES
buffer with iso-osmotic substitution of NaCl for 80 mM KCl).
After recording responses, cells were washed with HEPES
buffer and left to rest for 15 min before addition of another
reagent. At the end of each experiment the response to addition
of 10 μM cyclopiazonic acid was recorded to demonstrate
Ca2+ release from intracellular stores. Data were analyzed
using ImageJ (http://rSB431542web.nih.gov/ij/) software.
Gene Expression Profiling RNA was isolated from cells
grown (a) in expansion medium for 7 days, and (b) subse-
quently for 7 days in NPmedium exactly as we have described
previously [9] and above. Gene expression profiling was
performed by the Genome Centre, University of London,
London EC1M 6BQ, on a Human HT-12 v4 array using the
Illumina platform. The two profiles have been deposited in the
Gene Expression Omnibus (GEO); GEO accession number
GSE42678; http://www.ncbi.nlm.nih.gov/geo/.
Notes
1. Pre-differentiation of themultipotent hEPI-NCC into neural
stem cell-like cells is essential in our hands. Based on
morphology and early neuronal marker expression,
ex vivo expanded hEPI-NCSC did not differentiate effi-
ciently into neuroblasts. We thus rationalized that the
multipotent stem cells first have to be pre-differentiated into
neural stem cell-like cells. Based on our previous work
[16–19] and that of others [20–22] we developed an em-
pirical culture medium, termed neural progenitor 2 (NP2)
medium. After pre-treatment with NP2 medium, the origi-
nally stellate cells [9; Fig. 1A] changed their morphology
to elongated cells with short processes and they continued
to proliferate (Fig. 1B). Results from pilot experiments (not
shown) showed that minimum required exposure to NP2
medium was 24 h but could be extended to up to 6–7 days.
2. Inhibition of WNT signaling is important for long-term
maintenance of the neuronal phenotype. In the absence of
the WNT inhibitor, IWP-4, cells often, but not always,
started to lose neuronal morphology around day 14 of
differentiation and cells with neuronal morphology died
(Fig. 1C’, C”). In contrast, in the presence of increasing
doses of IWP-4, neuronal morphology and cell viability
were maintained (Fig. 1C). In addition, the continued
presence of SB431542 was required for maintaining
Table 1 Immunocytochemistry
Epitope Percent of total ±SEM
Culture day 5
OTX2 100
FOXA2 89.2±17.4
NURR1 93.1±11.1
EN1 0a
β-III tubulin 100
TH 100
Culture day 25
Dopamine 100
VMAT2 100
EN1 100
FOXA2 89.6±19.4
β-III tubulin 100
GIRK2 100
LMX1b 100
NURR1 100
PITX3 91.6±14.6
Synaptophysin 100
TH 100
Nestin 0
5-HT 0
Data expressed as average cell counts from 20 random fields of view per
antibody stain; average 3–12 cells per view. In the case of 100 % positive
cells, the entire culture was inspected to validate the scores
a Unspecific staining in the cytoplasm negatively affected imaging of low
nuclear stain
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neuronal morphology. Data from pilot experiments (not
shown) suggested that differentiation progressed in the
absence of CHIR99021. Exposure of the cells to a low
dose (0.5 μM) of CHIR99021 for 24 h, however, seemed
to accelerate/stabilize OTX2 expression. This low dose of
CHIR99021 was therefore routinely added to ensure re-
producibility. When the neurotrophins BDNF and GDNF
were added more than 4 days after addition of SHH (500
nM) and FGF8, all cells died (data not shown). To ensure
reproducibility, neurotrophins were therefore added at the
onset of differentiation. By day 25–29, cells had acquired
midbrain dopamine neuron morphology (Fig. 1D). The
experimental design is summarized in Fig. 2. By day 5,
the large majority of cells were immunoreactive for
OTX2, NURR1, FOXA1, TH and β-III tubulin. All cells
expressed immunoreactivity for OTX2, β-III tubulin and
perinuclear TH. Subsets of 89.2±17.4 % of cells
expressed FOXA2 and 93.1±11.1 % of cells expressed
NURR1. Punctate TH immunoreactivity was located in
perinuclear areas but not yet in distal processes (Fig. 3;
Table 1). By day 25, cells showed distinct neuronal mor-
phology. All cells were intensely immunopositive for the
midbrain marker genes, dopamine (Fig. 4a), vesicular
monoamine transporter-2 (VMAT2) (Fig. 4b), EN1
(Fig. 4c), β-III tubulin (Fig. 4d), NURR1 (Fig. 4e, E”),
LMX1b (Fig. 4f), GIRK2 (Fig. 4g), PITX3 (Fig. 4h),
FOXA2 (Fig. 4i, I’), synaptophysin (Fig. 4j) and TH
(Fig. 4k, l, m) (Table 1). FOXA2 immunoreactivity was
Fig. 4 Immunocytochemistry at day 25 in culture. aAll cells expressed
dopamine (DA); neuronal morphology is evident. b All cells were
immunoreactive for the vesicular transporter VMAT2. c EN1 was
expressed in all nuclei (inset) and also in perinuclear areas. d All
cells expressed the early neuronal marker, β-III tubulin. (E-E”)
NURR1/serotonin double stain. All cells expressed intense nuclear
NURR1 immunofluorescence (e, E”); (E’) background serotonin
(5HT) immunoreactivity; (E”) merged E and E’ images with blue DAPI
nuclear stain. fLMX1bwas expressed in all nuclei (inset). There was also
unspecific cytoplasmic fluorescence. gGIRK2 was expressed in all cells
(GIRK2/DAPI merged image). h PITX3 in 91.6±14.6 % of cells;
there was unspecific cytoplasmic fluorescence that interfered with
image acquisition; inset shows higher magnification of a nucleus. i
FOXA2 was localized in the nucleus of 89.6±19.4 % of cells. j
Synaptophysin/nestin double stain; (J’) all cells were intensely
synaptophysin immunoreactive whereas (J”) nestin immunoreactivity
was at background levels. k, l, m All cells expressed TH in the soma
and in processes. Bar, (a–m), 50 μm
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expressed by 89.6 % of cells (Table 1). Punctate TH
immunoreactivity was localized both in the somata and
processes. Immunoreactivity for 5-HT (Fig. 4E’) was at
background levels. Nestin immunofluorescence (Fig. 4J’)
was also detectable at background levels only. Cells main-
tained their neuronal morphology for a prolonged period of
time, as shown in Fig. 5. Quantitative PCR confirmed
expression of relevant genes at the RNA level (Table 2).
Comparison to cells isolated from human substantia nigra
demonstrated that expression levels were comparable to
those in human midbrain dopaminergic neurons in vivo
(Table 2). Whereas all scored cells expressed the dopami-
nergic neuron markers detailed above, 5.15±7.6 % of cells
also expressed KROX20. KROX20 is a hindbrain marker
[23] and also a Schwann cell marker [24]. This observation
indicates that a minority of cells co-expressed either a
hindbrain or glia trait.
3. As a measure of functional excitability, the intracellular
calcium changes to pertinent agonists were investigated.
Up to 83.2% of cells showed spontaneous Ca2+ activity in
the form of brief spatially restricted elevations; 80.9 % of
cells also responded to cyclopiazonic acid (CPA), which
empties internal calcium stores, and 77.0 % to KCl;
55.0 % of cells responded to acetylcholine, and 89.5 %
to ATP (Fig. 6), 53.6 % responded to L-glutamate, and
51.0 % to phenylephrine with prolonged and spatially
propagating Ca2+ elevations. These results suggested that
subsets of cells expressed functional purinergic receptors,
acetylcholine receptors, glutaminergic receptors and
alpha-1 adrenergic receptors (Table 3).
4. OTX2 expression, amarker gene for successful ventralising,
is essential for achieving the midbrain dopaminergic neu-
rons phenotype. OTX2, a floor plate marker, controls the
location of the isthmic organizer, which in turn defines the
ventromedial dopaminergic neuron domain [14].
Fig. 5 Dopamine immunocytochemistry at day 30 of culture. aDouble
stain with antibodies against dopamine (red fluorescence) and DAPI
nuclear stain (blue fluorescence) shows that all cells express dopamine
and have mature dopaminergic neuronal morphology. Contrast is
exaggerated in order to visualize fine processes. b Typical dopaminergic
neuron morphology at higher magnification showing punctate, presum-
ably vesicular, dopamine immunoreactivity
Table 2 qPCR – comparison in vitro differentiated hEPI-NCSC with
human substantia nigra
Gene Expression level
(Percent average of three HKG)
hEPI-NCSC DA
neurons
Human SN Percent
of SN
β-III tubulin 73.5±0.2 91.0 80.8±0.2
Tyrosine hydroxylase 73.3±0.9 85.0 86.3±1.0
Dopamine decarboxylase 68.6±1.5 75.0 91.5±2.0
Dopamine-β-hydroxylase 0 ND –
PNMT 71.0±0.7 100.4 70.7±0.7
NURR1 93.3±0.6 96.7 96.5±0.6
PITX3 67.7±0.3 79.7 84.9±0.4
EN1 81.5±1.6 94.4 86.3±1.7
LMX1b 70.1±2.7 80.9 86.6±3.3
VMAT2 70.3±0.4 81.8 85.7±3.3
GIRK2 63.7±0.7 85.2 72.7±0.2
FOXA2 65.6±1.4 84.4 72.1±1.7
DAT 63.4±1.0 73.5 86.3±1.4
HKG house keeping genes, SN adult human substantia nigra, ND not
detected
322 Stem Cell Rev and Rep (2014) 10:316–326
Expression of OTX2 was readily achieved in all hEPI-
NCSC. It is conceivable that neural crest cells are highly
susceptible to the SHH-mediated ventralizing signal be-
cause of their close ontological relationship with neural
tube progenitor cells. However, OTX2 expression is not
limited to the floor plate during embryonic development
but is expressed throughout the entire cephalic mesen-
chyme, including in neural crest cells [25, 26]. Mutations
in the OTX2 gene lead to neural crest-related craniofacial
malformations [27]. OTX2 expression is thus a physio-
logical event in the development of neural crest cells.
5. Blocking BMP and TGFβ signaling transiently with
LDN-193189 and SB431542 is part of current protocols
for differentiation of pluripotent stem cells into dopami-
nergic neurons (dual SMAD inhibition) [1–3]. In our
cultures dual SMAD inhibition needed to be constant,
which was likely due to the fact that hEPI-NCSC express
genes for TGFβs as well as for TGFβ receptors (GEO
accession number GSE42678). TGFβ signaling directs
neural stem cells towards the glia cell lineage [28], which
likely contributed to the unstable neuronal phenotype
of hEPI-NCSC derived neuroblasts in the absence, or
transient presence, of dual SMAD inhibition. Conversely,
Roussa et al. [29] recognized that TGFβ3 action is essential
for dopaminergic neuron differentiation. In our experiments
TGFβ3 was not essential for differentiating hEPI-NCSC
into midbrain dopaminergic neuroblasts, most likely
because hEPI-NCSC themselves express the TGFβ3
gene endogenously (GEO accession number GSE42678).
6. Timing and dose of the GSK-3β inhibitor, CHIR99021,
which is used to enhance canonical WNT signaling, were
critical in order to generate FOXA2/LMX1A double pos-
itive cells from human embryonic stem cells and iPS cells
[3, 30]. Thus, in culture as in the embryo, not only time
windows, but also concentration ranges are critical
Fig. 6 Spontaneous and agonist-mediated calcium responses. Spontane-
ous elevations of calcium were evident in the majority of cells and are
indicated by the white asterisks of three cells depicted in panels a–c. The
frames are 2.5 s apart. Purinergic-mediated calcium responses took the
form of spatially propagated waves as depicted in three cells depicted in
panels d–f. The frames are 2.5 s apart. The lineplots at the bottom of
panels a–f illustrate the F/F0 for time periods of 25 s or 50 s for
spontaneous (a–c) or agonist (d–f) changes respectively. Bars, 10 μm
Table 3 Calcium responses of differentiated cells
Agonist Percent responding cells ±SEM
Spontaneous activity 83.2±1.1
Acetylcholine (30 μM) 55.0±7.6
ATP (300 μM) 89.5±1.7
CPA (10 μM) 80.9±3.8
KCl (80 mM) 77.0±3.7
L-glutamate (50 μM) 53.6±6.4
Phenylephrine (10 μM) 51.0±5.0
CPA cyclopiazonic acid
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parameters for WNT signaling to specify midbrain dopa-
mine precursors. A short exposure of hEPI-NCSC to a
low dose of CHIR99021 was not essential for dopaminer-
gic differentiation, but was added to the experimental
design to ensure reproducibility. WNT5a is expressed in
NURR1+/TH+ cells in the developing midbrain [31].
WNT5a increases the portion of NURR1 positive cells
that have acquired a neuronal dopaminergic phenotype
[31–34]. In the present study expression of pertinent
midbrain dopaminergic neuron markers was achieved in
the absence of added WNT proteins and in the absence
of the GSK-3β inhibitor CHIR99021 (data not shown).
This may be attributed to the expression of the WNT5a
gene in hEPI-NCSC (GEO GSE42678). Conversely
LMX1b, which regulates WNT1 [35] may have re-
activated WNT1 expression in hEPI-NCSC derived
dopaminergic neurons.
7. LMX1b expression is essential for specifying midbrain
identity of dopaminergic neurons [36]. Continuous WNT
expression inhibits LMX1b expression. As hEPI-NCSC
are highly likely to express several WNT proteins (GEO
GSE42678), we added the WNT inhibitor, IWP-4 [37], in
order to avoid WNT-related inhibition of LMX1b. As
evidenced by cell morphology and marker expression,
the presence of IWP-4 contributed to a stabilization of
the neuronal phenotype and cellular health. Under these
conditions serotonin immunoreactivity was consistently
at background levels only.
8. Caudal to the isthmus, immediately adjacent to midbrain
dopaminergic neurons lie serotonergic neurons, which
later migrate dorsally within the rostral hindbrain and give
rise to the Raphe nuclei [35]. LMX1b/FOXA2 double
positive floor plate cells can also generate serotonergic
neurons of the rostral hindbrain whereas triple positive
LMX1b/FOXA2/PITX3 cells do not express serotonin
[14]. WNT5a, NURR1 and GDNF up-regulate PITX3
[31, 38, 39]. The development of more than one type of
neuron is a common occurrence in culture [30, 40–43].
Our current experimental design minimized this problem,
as 5-HT immunoreactivity was consistently at back-
ground levels. This is likely explained by the observation
that by day 25 all hEPI-NCSC-derived dopaminergic
neuroblasts express the three regulatory genes, LMX1b,
FOXA2 and PITX3.WNTsignaling specifies midbrain—
hindbrain identity in a dose-dependent manner, as
CHIR99021 in doses greater than 1 μM restricted the
human precursor cells to the hindbrain fate rather than
the midbrain fate [3]. This result is in agreement with
our observation that treatment of hEPI-NCSC with the
WNT inhibitor, IWP-4, contributed to the suppression
of serotonin expression. Wnt Inhibitor IWP-4 prevents
palmitylation of Wnt proteins by Porcupine (Porcn), a
membrane-bound O-acyltransferase, thereby blocking
Wnt secretion and activity. It also blocks phosphoryla-
tion of the Lrp6 receptor and accumulation of both
Dvl2 and β-catenin [37]. IWP-4 therefore also inhibits
Wnt5a. For this reason it is surprising that addition of
Wnt5a to up-regulate expression of PITX3 was not an
essential requirement in our protocol. There are several
possibilities that can explain this discrepancy. First, it is
conceivable that WNT5a action was completed by cul-
ture day 6, the point in time at which IWP-4 concen-
tration was increased to a conventionally used dose
[37]. Second, it is likely that NURR1 and GDNF
signalling, which also up-regulate PITX3 expression
compensated for a potential lack of WNT5a. This issue
could be dissected in more detail by using a WNT1-
specific inhibitor, such as XAV939 [44], in place of
IWP-4, as WNT5a is known to activate both the ca-
nonical and the PCP/RAC1 WNT signalling pathways
in mouse dopaminergic neurons [45, 46]. Third, the
sequence of events in dopaminergic neuron differentia-
tion might be different in human neural crest-derived
stem cells than in mouse pluripotent stem cells.
9. Contamination of dopaminergic neuron cultures with pro-
genitor cells is often a problem [3]. In contrast, we found
that with the current protocol there were no remaining
pools of nestin positive precursor cells left in day 25
cultures of hEPI-NCSC-derived dopaminergic neurons.
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